Rab7a is required to degrade select blood-brain barrier junctional proteins after ischemic stroke
A. Cottarelli, D. Jamoul, M. C. Tuohy, S. Shahriar, M. Glendinning, G. Prochilo, A. Edinger, A. Arac, D. Agalliu
This study shows Rab7a deletion reduces BBB dysfunction after ischemic stroke by preventing degradation of junctional proteins.
bioRxiv · Aug 29, 2023 · PreprintCell Biology